The University of Chicago Header Logo

Connection

Jeffrey Rathmell to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Jeffrey Rathmell has written about Dose-Response Relationship, Drug.
Jeffrey Rathmell
Connection Strength
0.033
Dose-Response Relationship, Drug
  1. BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia. Clin Cancer Res. 2021 01 15; 27(2):598-607.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.